FMM lauds govt’s Covid-19 immunisation models for manufacturing, related services sectors - MIDA | Malaysian Investment Development Authority
contrastBtngrayscaleBtn oku-icon


plusBtn crossBtn minusBtn


This site
is mobile


FMM lauds govt’s Covid-19 immunisation models for manufacturing, related services sectors

FMM lauds govt’s Covid-19 immunisation models for manufacturing, related services sectors

29 Apr 2021

KUALA LUMPUR (April 29): The Federation of Malaysian Manufacturers (FMM) has lauded the government’s two models of immunising workers in the manufacturing and related services sectors against Covid-19.

In a statement today, its president Tan Sri Soh Thian Lai said the models were unveiled by the Ministry of International Trade and Industry (MITI) during a consultation session with trade associations and chambers of commerce on April 26.

The two models are the public private partnership (PPP) immunisation model and the private immunisation model (special request) for business travellers.

The PPP immunisation model is aimed at local and foreign workers from manufacturing and related services sectors, based on the minimum threshold of 1,500 employees, including contractors or vendors working onsite who have already registered for the vaccine on the MySejahtera application, either per company or per site (a group of companies within a location/industrial estate coming together).

“In line with the PPP model, the government will cover the vaccine cost only, while companies will have to cover the vaccine administration cost including management of company panel/public doctors (approved by Protect Health) and the Vaccine Management Centre according to Ministry of Health’s specifications,” said Soh.

Meanwhile, the private immunisation model is aimed at either local employees or expatriates with employment passes and directors who have proof of importance of travel to be given priority vaccination for business purposes.

“Vaccination will be administered either by company panel (approved by Protect Health), Protect Health panel doctor or hospital/clinic identified by [Ministry of Health (MoH)], cost of which will have to be borne by the company. The government will only bear the cost of the vaccine,” he added.

According to Soh, companies keen to participate in either model will need to email their indication of interest to [email protected].

“The Covid-19 Immunisation Task Force (CITF) — Manufacturing and Related Services comprising MITI, MoH and Ministry of Science, Technology and Innovation (MOSTI) will assess each application for both models prior to giving a decision on the application including the next course of action,” he added.

“At this point in time, we understand that MITI, MoH and MOSTI are finalising the mechanisms to expedite both these models including identifying the necessary infrastructure and logistic solutions as well as the costs to be borne by the companies participating in this programme.

“We urge the manufacturing sector to do our part by supporting the Covid-19 Vaccination Programme for Manufacturing and Related Services for the wellbeing of all and the economy as a whole,” said Soh.

Source: The Edge Markets